GW confident epilepsy drug will get NHS funding despite NICE rejection

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 23, 2019 at 12:22 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,730
    Likes Received:
    3
    via The UK’s GW Pharma has insisted there will be no repeat of the controversy seen with cystic fibrosis drugs after NICE said “no” to regular NHS funding for its Epidyolex for rare forms of childhood epilepsy.

    article source